Comparison of Candida colonization in intensive care unit patients with and without COVID-19: First prospective cohort study from Turkey.

Candida CHROMagar Candida Plus COVID-19 colonization intensive care unit

Journal

Medical mycology
ISSN: 1460-2709
Titre abrégé: Med Mycol
Pays: England
ID NLM: 9815835

Informations de publication

Date de publication:
09 Apr 2024
Historique:
medline: 9 4 2024
pubmed: 9 4 2024
entrez: 9 4 2024
Statut: aheadofprint

Résumé

Candida species are the primary cause of fungal infections in intensive care units (ICUs). Despite the increasing prevalence of Candida-related infections, monitoring the progression of these infections from colonization in COVID-19 ICU patients lacks sufficient information. This study aims prospectively to compare 62 COVID-19 and 60 non-COVID-19 ICU patients from admission to discharge in terms of colonization development, rates, isolated Candida species, risk factors, and Candida infections during hospitalization. A total of 1464 samples collected at specific time intervals from various body sites [mouth, skin (axilla), rectal, and urine]. All samples were inoculated onto CHROMagar Candida and CHROMagar Candida Plus media, with isolates identified using MALDI-TOF MS. COVID-19 patients exhibited significantly higher colonization rates in oral, rectal, and urine samples compared to non-COVID-19 patients, (p<0.05). Among the Candida species, non-albicans Candida was more frequently detected in COVID-19 patients, particularly in oral (75.8%-25%; p<0.001) and rectal regions (74.19%-46.66%; p< 0.05). Colonization with mixed Candida species was also more prevalent in the oropharyngeal region (p<0.05). Mechanical ventilation and corticosteroid use emerged as elevated risk factors among COVID-19 patients (p<0.05). Despite the colonization prevalence, both COVID-19-positive and negative patients exhibited low incidences of Candida infections, with rates of 9.67% (n=6/62) and 6.67% (n=3/60), respectively. Consequently, although Candida colonization rates were higher in COVID-19 ICU patients, there was no significant difference in Candida infection development compared to the non-COVID-19 group. However, the elevated rate of non-albicans Candida isolates highlights potential future infections, particularly given their intrinsic resistance in prophylactic or empirical treatments if needed. Additionally, the high rate of mixed colonization emphasizes the importance of using chromogenic media for routine evaluation. This is the first prospective cohort study comparing Candida colonization features including species and body sites from the time of admission to the externalization in ICU patients with and without COVID-19. It provides key points that can be referenced for fungal approaches in future disasters.

Autres résumés

Type: plain-language-summary (eng)
This is the first prospective cohort study comparing Candida colonization features including species and body sites from the time of admission to the externalization in ICU patients with and without COVID-19. It provides key points that can be referenced for fungal approaches in future disasters.

Identifiants

pubmed: 38592959
pii: 7642854
doi: 10.1093/mmy/myae035
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Informations de copyright

© The Author(s) 2024. Published by Oxford University Press on behalf of The International Society for Human and Animal Mycology.

Auteurs

Ilvana Çaklovica Küçükkaya (I)

Department of Medical Microbiology, Istanbul Faculty of Medicine, Istanbul University, Istanbul, Turkey.

Günseli Orhun (G)

Department of Anaesthesiology and Reanimation, Istanbul Faculty of Medicine, Istanbul University, Istanbul, Turkey.

Arif Atahan Çağatay (A)

Department of Infectious Diseases and Clinical Microbiology Infectious Diseases, Istanbul Faculty of Medicine, Istanbul University, Istanbul, Turkey.

Sadık Kalaycı (S)

Genetics and Bioengineering Department, Faculty of Engineering Yeditepe University, Istanbul, Turkey.

Figen Esen (F)

Department of Anaesthesiology and Reanimation, Istanbul Faculty of Medicine, Istanbul University, Istanbul, Turkey.

Fikrettin Şahin (F)

Genetics and Bioengineering Department, Faculty of Engineering Yeditepe University, Istanbul, Turkey.

Ali Ağaçfidan (A)

Department of Medical Microbiology, Istanbul Faculty of Medicine, Istanbul University, Istanbul, Turkey.

Zayre Erturan (Z)

Department of Medical Microbiology, Istanbul Faculty of Medicine, Istanbul University, Istanbul, Turkey.

Classifications MeSH